Basic Information
ID: ALA2393846
Type: Functional
Description: Inhibition of VAP-1 in streptozotocin-induced diabetic Sprague-Dawley rat plasma using [14C]-benzylamine as substrate at 10 mg/kg, po administered for 2 weeks after streptozotocin-challenge by scintillation spectrometric analysis
Organism: Rattus norvegicus
Strain: Sprague-Dawley
Tissue: Plasma
Activity Charts
Bioactivity
Activity Types for Assay ALA2393846
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 377.90 | 2.78 | 2.78 |